CPHI Milan 2026
10/2026 – 10/2026
会社概要
- 正式社名: Yuxi Walvax Biotechnology Co., Ltd.
- 登録国: China
- 住所: 83 South Dongfeng Road, Yuxi • Yunnan
- 従業員数: 1000 - 4999
- 設立年: 2001
説明:
Founded in 2001, Walvax Biotechnology Co. Ltd. is mainly engaged in researching, developing, manufacturing and distributing safe, efficacious human vaccines. A leading publicly listed company in China, Walvax has successfully developed 9 licensed vaccines (13 presentations), including the world's 2nd approved PCV-13 vaccine, 4th approved mRNA COVID-19 vaccine, and 5th approved HPV vaccine.
事業活動
バイオ医薬品
輸出業者製造業者
ATC分類(解剖治療化学分類)
製造業者
販売市場
- South Asia: Bangladesh, India
- Mainland Southeast Asia: Indonesia, Philippines
- Central Asia: Kyrgyzstan, Uzbekistan
- Northern Africa: Egypt, Morocco
- Western Africa: Nigeria, Senegal
当社の製品・サービス
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · ATC (Anatomical Therapeutic Chemical) Classification
証明
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す